- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 7/02 - Linear peptides containing at least one abnormal peptide link
Patent holdings for IPC class C07K 7/02
Total number of patents in this class: 684
10-year publication summary
|
48
|
38
|
66
|
72
|
51
|
60
|
63
|
48
|
41
|
13
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1152 |
78 |
| Protagonist Therapeutics, Inc. | 137 |
22 |
| Centre National de La Recherche Scientifique | 10321 |
11 |
| SeaGen Inc | 580 |
11 |
| CARA Therapeutics, Inc. | 68 |
10 |
| University of South Florida | 1812 |
8 |
| L.e.a.f. Holdings Group LLC | 107 |
8 |
| Shenzhen HighTide Biopharmaceutical, Ltd. | 56 |
8 |
| The Regents of the University of California | 19812 |
7 |
| Pfizer Inc. | 3367 |
7 |
| Mersana Therapeutics, Inc. | 103 |
7 |
| Provincial Health Services Authority | 184 |
7 |
| Novartis AG | 10904 |
6 |
| Wisconsin Alumni Research Foundation | 3864 |
6 |
| The University of British Columbia | 1492 |
6 |
| Genentech, Inc. | 3961 |
5 |
| Takeda Pharmaceutical Company Limited | 2704 |
5 |
| Deutsches Krebsforschungszentrum | 418 |
5 |
| Regeneron Pharmaceuticals, Inc. | 4223 |
5 |
| Bicyclerd Limited | 143 |
5 |
| Other owners | 457 |